

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:


(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reported a dip in annual revenue for 2022, as profit tumbled due to high inflation and adjustm...


(Alliance News) - Stock prices in London opened mixed on Thursday, with large-cap indices underperforming amid mixed corporate earnings.


(Sharecast News) - Hikma Pharmaceuticals posted lower full-year profits as stiff competition in generics saw its top line growth flatten out.


(Alliance News) - Stocks in London were called to open slightly higher on Thursday, as investors were unfazed by a fairly uneventful set of policy mee...


Hikma claims Amarin used exclusive agreements with suppliers to frustrate generic rivals *


(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning: